The use of peptides in active pharmaceutical ingredients (API)

In total, there are more than 40 peptides on the pharmaceutical world market. However, there are still more than 100 peptides in several clinical phases. Due to the enhanced drug delivery technology of peptides, research have rekindled their interest in peptides. The manufacturing of most of these drugs has benefited from new technological advances. Therefore, several serious diseases can be treated using the potential next generation of peptide drugs.

Ansynth supports pharmaceutical companies in the development of active pharmaceutical ingredients. Our specialism is to determine the right analysis procedure to characterize the specific peptide.